We are monitoring the impact of COVID-19 on Latin America Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Share on

Latin America Hormone Replacement Therapy Market Research Report - SegmentedBy Hormone Type, Route Of Administration & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 901
Pages: 132

Latin America Hormone Replacement Therapy Market Size & Growth (2022 to 2027):

As per the research report, the size of the Latin America Hormone Replacement Therapy Market Size is valued at USD 1.70 billion in 2022 and is predicted to reach USD 2.47 billion by 2027, growing at a CAGR of 7.75% during the forecast period 2022 to 2027.

The rising awareness of postmenopausal concerns among women is a significant growth factor for the Latin American hormone replacement therapy market. Other notable growth factors are the availability of new formulations and unmet medical needs that necessitate the use of hormone treatment.

As people get older, their health issues grow, leading to an increase in chronic illness in the population. Hormonal imbalance is required to lessen the impact of diseases. Due to the behavioral changes in women's lifestyles, hormones such as progesterone and estrogen play a critical role in nursing women; there is a high demand for hormone therapy in the pre and post-pregnancy and lactating periods, respectively. 

Apart from these factors, the hormone replacement treatment market is being driven by increased spending on research and development and greater public awareness of health issues. Moreover, these types of safe hormone replacement therapy are available to impotent males and persons with medical illnesses. Therefore, increased investment in such advanced treatments in emerging nations presents a significant opportunity for market traders to expand and capture the segment in such countries.

However, various side effects have been involved with replacement therapy: bleeding, headaches, nausea, heart disease, stroke, and others. 

In addition, the high cost of the therapy keeps it out of reach for the middle class. Furthermore, women with high-risk coronary artery disease are advised to avoid hormone replacement treatment; reducing the size of the target audience is the factor hampering the market growth. 

This research report on the Latin America Hormone Replacement Therapy Market has been segmented and sub-segmented into the following categories:

By Hormone Type:

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement Therapy
  • Thyroid replacement therapy
  • others

By Route of Administration:

  • Oral
  • Transdermal
  • Parenteral
  • other routes

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Latin America is anticipated to account for a promising share in the Hormone replacement therapy market during the forecast period. The need for estrogen replacement in Latin America is expected to be driven by a diverse variety of target population bases across the region. Furthermore, governments' increasing focus on women's healthcare is expected to positively impact the reviewed market's advancement over the forecast period.

Brazil hormone replacement therapy market is the world's ninth-largest and one of the fastest expanding economies, dominates the market in this region due to economic conditions and women's awareness. Brazil has potential growth as a result of the government's recent focus on the testosterone issue. In addition, the government's increased healthcare spending is fueling the growth of Brazil's hormone replacement treatment market to a great extent.

The rising of the hormone replacement treatment industry in Mexico hormone replacement therapy market has been aided by the country's growing population and increased healthcare spending. Furthermore, universal healthcare is regarded as one of the most comprehensive health care plans currently altering the country's healthcare infrastructure. Moreover, Mexico previously spent a substantial amount on a person's healthcare. As a result, such improvements in the healthcare sector are expected to provide the Mexican hormone replacement treatment market with several new chances throughout the forecast period.

KEY MARKET PLAYERS

Prominent companies leading in the Latin America Hormone Replacement Therapy Market profiled in the report are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co, Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc

1.Introduction         

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                

2. Research Methodology                  

                2.1 Introduction     

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview             

                3.1 Executive Summary                                

                3.2 Key Inferences

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers 

                4.2 Market Restraints                                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                     

                 5.1 By Hormone Type                                   

                                5.1.1 Estrogen Replacement Therapy                     

                                5.1.2 Growth Hormone Replacement Therapy                   

                                5.1.3 Thyroid Replacement Therapy                       

                                5.1.4 Others                      

                5.2 By Route of Administration                                 

                                5.2.1 Oral                            

                                5.2.2 Parenteral               

                                5.2.3 Transdermal                           

                                5.2.4 Others                      

6. Geographical Analysis                     

                                6.1 Introduction                              

                                6.2 Brazil                             

                                6.3 Mexico                         

                                6.4 Rest of Latin America                             

7. Pipeline Product Analysis              

                7.1 Overview           

                7.2 Pipeline Development Landscape           

                7.3 Molecular Targets in the Pipeline            

                7.4 Clinical Trials    

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8.Strategic Analysis               

                8.1 PESTLE analysis

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis     

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9.Market Leaders' Analysis                 

                9.1 Abbott Laboratories                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Financial analysis                  

                                9.1.4 Recent Developments                       

                                9.1.5 SWOT analysis                       

                                9.1.6 Analyst View                          

                9.2 Novartis                                       

                9.3 Pfizer   

                9.4 Mylan Laboratories                                 

                9.5 Amgen

                9.6 Merck & Co.                               

                9.7 Bayer   

                9.8 Eli Lily & Company                                  

                9.9 Novo Nordisk   

                9.10 Wyeth                                        

                9.11 F. Hoffmann-La Roche

                9.12 Hisamitsu Pharmaceutical  Co. Inc.                                 

10.Competitive Landscape                 

                10.1 Market share analysis 

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11.Expert Opinions                

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                  

                a) List of Tables                                

                b) List of Figures     

  1. Latin America Hormone Replacement Therapy Market By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Hormone Replacement Therapy Market By Hormone Type, From 2022 - 2027 (USD Billion)
  3. Latin America Estrogen Replacement Therapy Market By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Growth Hormone Replacement Therapy Market By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Thyroid Replacement Therapy Market By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Other Hormone Therapies Market By Region, From 2022 - 2027 (USD Billion)
  7. Argentina Hormone Replacement Therapy Market By Hormone Type, From 2022 - 2027 (USD Billion)
  8. Argentina Hormone Replacement Therapy Market By Route of Administration, From 2022 - 2027 (USD Billion)
  9. Brazil Hormone Replacement Therapy Market By Hormone Type, From 2022 - 2027 (USD Billion)
  10. Brazil Hormone Replacement Therapy Market By Route of Administration, From 2022 - 2027 (USD Billion)
  11. Mexico Hormone Replacement Therapy Market By Hormone Type, From 2022 - 2027 (USD Billion)
  12. Mexico Hormone Replacement Therapy Market By Route of Administration, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample